TRIM17

gene
On this page

Also known as terfRBCC

Summary

TRIM17 (tripartite motif containing 17, HGNC:13430) is a protein-coding gene on chromosome 1q42.13, encoding E3 ubiquitin-protein ligase TRIM17 (Q9Y577). E3 ubiquitin ligase that plays important roles in the regulation of neuronal apoptosis, selective autophagy or cell proliferation.

The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein is expressed almost exclusively in the testis, but its function is unknown. Multiple alternatively spliced transcript variants have been found for this gene.

Source: NCBI Gene 51127 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 90 total
  • MANE Select transcript: NM_016102

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:13430
Approved symbolTRIM17
Nametripartite motif containing 17
Location1q42.13
Locus typegene with protein product
StatusApproved
Aliasesterf, RBCC
Ensembl geneENSG00000162931
Ensembl biotypeprotein_coding
OMIM606123
Entrez51127

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 10 protein_coding

ENST00000295033, ENST00000355586, ENST00000366697, ENST00000366698, ENST00000456946, ENST00000457345, ENST00000479800, ENST00000520264, ENST00000882179, ENST00000882180

RefSeq mRNA: 3 — MANE Select: NM_016102 NM_001024940, NM_001134855, NM_016102

CCDS: CCDS1571, CCDS44327

Canonical transcript exons

ENST00000366698 — 7 exons

ExonStartEnd
ENSE00001069942228409389228409411
ENSE00001069944228413797228413892
ENSE00001069945228410946228411176
ENSE00001413601228416539228416861
ENSE00001416217228414644228415113
ENSE00003789613228409172228409275
ENSE00003841324228407935228408751

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 92.09.

FANTOM5 (CAGE): breadth broad, TPM avg 1.6471 / max 91.5525, expressed in 465 samples.

FANTOM5 promoters (9 alternative TSS)

Promoter IDTPM avgSamples expressed
178360.4278232
178390.4218214
178370.2545115
178400.2487119
178340.117758
178380.075829
178330.043328
178350.038514
178320.01905

Top tissues by expression

135 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right hemisphere of cerebellumUBERON:001489092.09gold quality
cerebellar hemisphereUBERON:000224591.92gold quality
cerebellar cortexUBERON:000212991.86gold quality
cerebellumUBERON:000203791.82gold quality
left testisUBERON:000453388.96gold quality
right testisUBERON:000453488.73gold quality
testisUBERON:000047388.29gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.02gold quality
nucleus accumbensUBERON:000188285.94gold quality
caudate nucleusUBERON:000187383.83gold quality
right frontal lobeUBERON:000281083.35gold quality
putamenUBERON:000187482.58gold quality
superior frontal gyrusUBERON:000266181.29gold quality
Brodmann (1909) area 9UBERON:001354081.02gold quality
frontal cortexUBERON:000187080.19gold quality
dorsolateral prefrontal cortexUBERON:000983479.71gold quality
cerebral cortexUBERON:000095678.47gold quality
brainUBERON:000095578.17gold quality
prefrontal cortexUBERON:000045177.94gold quality
anterior cingulate cortexUBERON:000983577.27gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099177.08gold quality
primary visual cortexUBERON:000243676.99gold quality
right uterine tubeUBERON:000130276.72gold quality
Ammon’s hornUBERON:000195476.46gold quality
temporal lobeUBERON:000187173.06gold quality
spleenUBERON:000210672.95gold quality
amygdalaUBERON:000187672.86gold quality
hypothalamusUBERON:000189872.30gold quality
granulocyteCL:000009471.20gold quality
right ovaryUBERON:000211870.92gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.22

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): NKX3-1

miRNA regulators (miRDB)

6 targeting TRIM17, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-3059-5P99.7069.932491
HSA-MIR-124698.5466.21959
HSA-MIR-427798.3467.171323
HSA-MIR-365097.8864.89693
HSA-MIR-7848-3P95.6965.00363

Literature-anchored findings (GeneRIF, showing 9)

  • terf interacts with TRIM44;TRIM44 inhibited ubiquitination of terf, and thus stabilized the protein. (PMID:19358823)
  • the E3 ubiquitin ligase terf causes protein degradation of ZWINT and negatively regulates cell proliferation (PMID:22023800)
  • NFATc3 interacted in a SUMO-dependent manner with Trim17, an E3 ubiquitin ligase necessary for neuronal apoptosis (PMID:25215946)
  • TRIM17 promoted the removal of midbodies, remnants of the cell division machinery that are known autophagy targets. (PMID:27562068)
  • overexpression of TRIM28 or knock-out of TRIM17 reduced BCLA1 protein levels and restored sensitivity of melanoma cells to BRAF-targeted therapy. Therefore, our data describe a molecular rheostat in which two proteins of the TRIM family antagonistically regulate BCL2A1 stability and modulate cell death. (PMID:30042493)
  • deregulation of the TRIM17/TRIM41/ZSCAN21 pathway may be involved in the pathogenesis of Parkinson’s disease. (PMID:30485814)
  • data suggest LSD1 largely plays a tumor suppressor role in luminal breast cancer and the oncogenic program associated with LSD1-inhibition may be suppressed via TRIM37-inhibition (PMID:31409898)
  • MiR-1246 is responsible for lung cancer cells-derived exosomes-mediated promoting effects on lung cancer stemness via targeting TRIM17. (PMID:35894553)
  • TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer. (PMID:37219768)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusTrim17ENSMUSG00000036964
rattus_norvegicusTrim17ENSRNOG00000022983

Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM48 (ENSG00000150244), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890)

Protein

Protein identifiers

E3 ubiquitin-protein ligase TRIM17Q9Y577 (reviewed: Q9Y577)

Alternative names: RING finger protein 16, RING-type E3 ubiquitin transferase TRIM17, Testis RING finger protein, Tripartite motif-containing protein 17

All UniProt accessions (5): E5RI62, E5RJW6, Q9Y577, J3KNZ3, J3KQG0

UniProt curated annotations — full annotation on UniProt →

Function. E3 ubiquitin ligase that plays important roles in the regulation of neuronal apoptosis, selective autophagy or cell proliferation. Stimulates the degradation of kinetochore ZW10 interacting protein ZWINT in a proteasome-dependent manner, leading to negative regulation of cell proliferation. Inhibits autophagic degradation of diverse known targets while contributing to autophagy of midbodies. Autophagy-inhibitory activity involves MCL1, which TRIM17 assembles into complexes with the key autophagy regulator BECN1. Controls neuronal apoptosis by mediating ubiquitination and degradation of MCL1 to initiate neuronal death. In addition, regulates NFAT transcription factors NFATC3 and NFATC4 activities by preventing their nuclear localization, thus inhibiting their transcriptional activities. Decreases TRIM41-mediated degradation of ZSCAN2 thereby stimulating alpha-synuclein/SNCA transcription in neuronal cells. Prevents the E3 ubiquitin-ligase activity of TRIM28 and its interaction with anti-apoptotic BCL2A1, blocking TRIM28 from ubiquitinating BCL2A1.

Subunit / interactions. Interacts (via coiled coil) with TRIM44 (via coiled coil). Interacts with TRIM28; this interaction prevents TRIM28 activity on BCL2A1. Interacts with TRIM41; this interaction prevents TRIM41 activity on ZSCAN2. Interacts with BECN1. Interacts with NFATC3 and NFATC4; these interactions prevent NFATC3 and NFATC4 nuclear localization.

Subcellular location. Cytoplasm. Lysosome.

Tissue specificity. Almost exclusively in the testis.

Post-translational modifications. Auto-ubiquitinated.

Pathway. Protein modification; protein ubiquitination.

Similarity. Belongs to the TRIM/RBCC family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9Y577-11yes
Q9Y577-22

RefSeq proteins (3): NP_001020111, NP_001128327, NP_057186* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000315Znf_B-boxDomain
IPR001841Znf_RINGDomain
IPR001870B30.2/SPRYDomain
IPR003877SPRY_domDomain
IPR003879Butyrophylin_SPRYDomain
IPR006574PRYDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR013320ConA-like_dom_sfHomologous_superfamily
IPR017907Znf_RING_CSConserved_site
IPR027370Znf-RING_eukDomain
IPR035687TRIM17_PRY/SPRYDomain
IPR043136B30.2/SPRY_sfHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00622, PF00643, PF13445

UniProt features (11 total): binding site 4, splice variant 2, zinc finger region 2, chain 1, domain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y577-F186.170.55

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 99; 102; 121; 127

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-877300Interferon gamma signaling

MSigDB gene sets: 45 (showing top): REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_PROTEIN_AUTOUBIQUITINATION, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MARSON_BOUND_BY_FOXP3_STIMULATED, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, CHYLA_CBFA2T3_TARGETS_DN, GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM, DELACROIX_RAR_BOUND_ES, ALK_DN.V1_DN, NRL_DN.V1_DN

GO Biological Process (6): autophagy (GO:0006914), regulation of gene expression (GO:0010468), regulation of protein localization (GO:0032880), innate immune response (GO:0045087), protein autoubiquitination (GO:0051865), protein ubiquitination (GO:0016567)

GO Molecular Function (7): ubiquitin-protein transferase activity (GO:0004842), zinc ion binding (GO:0008270), protein-macromolecule adaptor activity (GO:0030674), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), transferase activity (GO:0016740), metal ion binding (GO:0046872)

GO Cellular Component (2): cytoplasm (GO:0005737), lysosome (GO:0005764)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Interferon Signaling1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
gene expression1
regulation of macromolecule biosynthetic process1
intracellular protein localization1
regulation of localization1
immune response1
defense response to symbiont1
protein ubiquitination1
protein modification by small protein conjugation1
ubiquitin-like protein transferase activity1
transition metal ion binding1
protein binding1
molecular adaptor activity1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
catalytic activity1
cation binding1
intracellular anatomical structure1
cellular anatomical structure1
lytic vacuole1

Protein interactions and networks

STRING

792 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TRIM17BBOX1O75936977
TRIM17RBCK1Q9BYM8959
TRIM17TRAT1Q6PIZ9924
TRIM17TRIM28Q13263858
TRIM17TRIM24O15164804
TRIM17TRIM9Q9C026793
TRIM17TRIM66O15016786
TRIM17TINF2Q9BSI4780
TRIM17TRIM67Q6ZTA4755
TRIM17PMLP29590741
TRIM17TRIM33Q9UPN9731
TRIM17TMLHEQ9NVH6715
TRIM17PRYO14603694
TRIM17KCNRGQ8N5I3573
TRIM17TRIM32Q13049571

IntAct

42 interactions, top by confidence:

ABTypeScore
TRIM39TRIM17psi-mi:“MI:0915”(physical association)0.860
TRIM17TRIM39psi-mi:“MI:0915”(physical association)0.860
HGSTRIM17psi-mi:“MI:0915”(physical association)0.720
TRIM41TRIM17psi-mi:“MI:0915”(physical association)0.670
MEOX2TRIM17psi-mi:“MI:0915”(physical association)0.560
TRIM17HSP90AB1psi-mi:“MI:0915”(physical association)0.400
MLF1TRIM17psi-mi:“MI:0915”(physical association)0.400
HSP90AB1TRIM17psi-mi:“MI:0915”(physical association)0.400
TRIM17psi-mi:“MI:0915”(physical association)0.400
NUDCTRIM17psi-mi:“MI:0915”(physical association)0.400
NUDCD3TRIM17psi-mi:“MI:0915”(physical association)0.400
TRIM17CACYBPpsi-mi:“MI:0915”(physical association)0.400
TRIM17AARSD1psi-mi:“MI:0915”(physical association)0.400
TRIM17UBE2Wpsi-mi:“MI:0915”(physical association)0.370
UBE2D1TRIM17psi-mi:“MI:0915”(physical association)0.370
TRIM17UBE2D2psi-mi:“MI:0915”(physical association)0.370
TRIM17UBE2D3psi-mi:“MI:0915”(physical association)0.370
UBE2HTRIM17psi-mi:“MI:0915”(physical association)0.370

BioGRID (107): TRIM39 (Two-hybrid), TRIM39 (Two-hybrid), TRIM44 (Affinity Capture-MS), SNX2 (Affinity Capture-MS), TRIM17 (Reconstituted Complex), TRIM17 (Reconstituted Complex), TRIM17 (Two-hybrid), BCL2A1 (Affinity Capture-Western), TRIM17 (Affinity Capture-Western), TRIM28 (Affinity Capture-Western), TRIM28 (Co-localization), TRIM17 (Co-fractionation), TRIM17 (Affinity Capture-RNA), TRIM39 (Two-hybrid), TRIM17 (Two-hybrid)

ESM2 similar proteins: A0JN74, A6NCK2, A6NGJ6, A6NI03, B1H278, K7N6K2, O00478, O00481, P14373, P19474, Q13410, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q1XHU0, Q2YEM8, Q2YEM9, Q3ZEE5, Q587N6, Q5C8T6, Q5C8T8, Q5C8U1, Q5D7I9, Q5D7J0, Q5D7J1, Q5NCC9, Q5R996, Q62158, Q6MFZ5, Q7YR33, Q7YRV4, Q80V85, Q8BGE7, Q8NG06, Q923T7, Q96BQ3, Q96F44, Q99PP6, Q99PQ2

Diamond homologs: A0JN74, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NK02, A6NLI5, B1H278, C9J1S8, K7N6K2, O00635, O15553, O19085, O77666, P0CI25, P0CI26, P14373, P15533, P18892, P19474, Q02084, Q0PF16, Q12899, Q13410, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q1XHU0, Q2T9Z0, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3UWZ0, Q3ZEE5, Q495X7, Q587N6, Q587N7, Q58DK8

SIGNOR signaling

2 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”TRIM17ubiquitination
TRIM17“down-regulates quantity by destabilization”MCL1polyubiquitination

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Antigen processing: Ubiquitination & Proteasome degradation920.9×1e-08

GO biological processes:

GO termPartnersFoldFDR
protein K48-linked ubiquitination540.1×1e-05
protein polyubiquitination738.5×6e-08
ubiquitin-dependent protein catabolic process517.7×3e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

90 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign10
Benign5

Top pathogenic / likely-pathogenic (0)

SpliceAI

833 predictions. Top by Δscore:

VariantEffectΔscore
1:228410943:CA:Cdonor_loss1.0000
1:228410944:A:ACdonor_gain1.0000
1:228410945:C:CCdonor_gain1.0000
1:228410945:CCTG:Cdonor_gain1.0000
1:228411173:TGCC:Tacceptor_gain1.0000
1:228411174:GCC:Gacceptor_gain1.0000
1:228411175:CCC:Cacceptor_gain1.0000
1:228411177:C:Aacceptor_loss1.0000
1:228411177:C:CCacceptor_gain1.0000
1:228411178:T:Cacceptor_loss1.0000
1:228411180:C:CTacceptor_gain1.0000
1:228411181:A:Tacceptor_gain1.0000
1:228413792:CCCA:Cdonor_loss1.0000
1:228413793:CCAC:Cdonor_loss1.0000
1:228413794:CACC:Cdonor_loss1.0000
1:228413795:ACC:Adonor_loss1.0000
1:228413796:CC:Cdonor_loss1.0000
1:228413889:TCAA:Tacceptor_gain1.0000
1:228413890:CAA:Cacceptor_gain1.0000
1:228413890:CAAC:Cacceptor_gain1.0000
1:228413891:AAC:Aacceptor_loss1.0000
1:228413892:AC:Aacceptor_loss1.0000
1:228413893:C:CAacceptor_loss1.0000
1:228413893:C:CCacceptor_gain1.0000
1:228413894:T:Aacceptor_loss1.0000
1:228414639:CCTAC:Cdonor_loss1.0000
1:228414641:TAC:Tdonor_loss1.0000
1:228414643:CCTTG:Cdonor_loss1.0000
1:228408411:CGGGG:Cacceptor_gain0.9900
1:228408412:G:Tacceptor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000351108 (1:228412539 T>C), RS1000457459 (1:228411845 C>G,T), RS1000890667 (1:228416903 G>A), RS1001100528 (1:228417410 G>A), RS1001595743 (1:228414446 A>G), RS1001752263 (1:228417944 A>T), RS1001974677 (1:228409855 C>G), RS1001996470 (1:228411651 G>A), RS1002025669 (1:228409490 G>A,C,T), RS1002137909 (1:228415576 CTT>C), RS1002490379 (1:228415797 A>T), RS1002609501 (1:228407680 G>C), RS1002723970 (1:228416418 G>A,C,T), RS1003076069 (1:228410191 G>A), RS1003633626 (1:228418813 A>T)

Disease associations

OMIM: gene MIM:606123 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006276_1Non-Richardson’s syndrome vs Richardson’s syndrome in progressive supranuclear palsy2.000000e-09

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
GSK-J4decreases expression1
2-palmitoylglycerolincreases expression1
rofecoxibaffects expression1
jinfukangaffects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation, decreases methylation1
Cadmiumdecreases expression1
Cisplatinaffects cotreatment, increases expression1
Plant Extractsaffects cotreatment, decreases expression1
Tobacco Smoke Pollutiondecreases expression1
Valproic Acidincreases methylation1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): progressive supranuclear palsy